DNA Link, Inc. provides genomic analysis services. Its services include next-generation sequencing, microarray, genotyping, patient-derived xenograft, AccuID, and DNA genomics personalized service. The company was founded on March 15, 2000 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company